Clinical trial Recruiting at 5 sites Interventional Ages 12 to 70

Understanding predictors of treatment response in Dialectical Behaviour Therapy for self-harm and borderline personality disorder

Official title: Predictors of Clinical Course and Treatment Response in Patients Having Received Dialectical Behaviour Therapy Delivered by Clinical Units in the Norwegian Network for Clinical Evaluation and Quality in DBT Programmes

Run by Oslo University Hospital · NCT04318899 · Data updated 2026-11-12

This study is trying to find out what factors help predict how well Dialectical Behaviour Therapy works for people with self-harm and borderline personality disorder.

Quick facts

Study typeInterventional
Ages12 Years to 70 Years
SexAll
Enrollment250 (estimated)
SponsorOslo University Hospital
Academic / other
Locations5 sites (Oslo, Oslo and 4 other locations)
StatusRecruiting
StartedJanuary 1, 2018
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedOctober 16, 2026
Trial IDNCT04318899 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with a history of repeated deliberate self-harm and a diagnosis of borderline personality disorder.

Probably not a fit

Patients with psychotic disorders, anorexia nervosa, substance dependence disorder, or autism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project collaborates with various clinical units in Norway to establish a platform for delivering and evaluating Dialectical Behaviour Therapy (DBT) for patients with self-harm and borderline personality disorder. It aims to systematically collect data on patient characteristics and treatment outcomes to identify predictors of clinical course and response to therapy. The study will analyze factors such as sociodemographic variables, psychiatric diagnoses, and previous treatment history to understand their impact on treatment effectiveness. By utilizing a uniform protocol for assessments, the research seeks to enhance the quality of DBT and improve patient care.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with borderline personality disorder and self-harming behaviors.

How similar studies have gone: Other studies have shown success in using DBT for similar conditions, indicating that this approach is both tested and promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* History of repeated deliberate self harm
* Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion.

Exclusion Criteria:

* Psychotic disorders
* Anorexia Nervosa
* Substance dependence disorder
* Mental retardation (IQ less than 70)
* Asperger syndrome/autism

Where it's running

  • Søndre Oslo DPS/Oslo Universitetssykehus HF
    Oslo, Oslo, Norway
    Recruiting
  • Moss DPS/Østfold sykehus HF
    Moss, Norway
    Recruiting
  • Psykiatrisk senter ytre Helgeland/Helgelandssykehuset HF
    Sandnessjøen, Norway
    Recruiting
  • Bjerketun behandlingshjem/Vestreviken HF
    Sandvika, Norway
    Recruiting
  • BUP Lian/St Olavs Hospital HF
    Trondheim, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Understanding emotional dysregulation in self-harm behaviors

    This study is testing if Dialectical Behavior Therapy can help people who self-harm by improving their emotional control and reducing the frequency and intensity of their self-injury.

    Recruiting Haukeland University Hospital · Bergen · NCT03846375

  • Enhanced DBT skills group for Borderline Personality Disorder

    This study tests whether a 12-week DBT skills group helps reduce self-harm and suicidal behavior in people with borderline personality disorder better than a shorter 6-month program or usual care.

    Recruiting at 7 sites Hospital Dr Sotero del Rio · Padre Las Casas, Araucania and 6 other locations · NCT07875166

  • Blended ERITA for Teens Who Self-Injure

    A blended, youth-focused therapy test combines in-person sessions with digital tools to help teens who have recently self-injured see if this approach improves emotion regulation and daily functioning.

    Recruiting Karolinska Institutet · Stockholm · NCT07755774

  • Internet-delivered Emotion Regulation Therapy for Adolescents with NSSI

    This trial tests whether a flexible, internet-based therapy for teens who self-injure can be more effective than standard online treatment for reducing nonsuicidal self-injury symptoms.

    Recruiting Karolinska Institutet · Stockholm · NCT07573085

  • Long-term outcomes after MBT for borderline personality disorder

    This long-term follow-up checks how people with borderline personality disorder who received MBT in the past are doing more than 10 years later and whether the two MBT formats differ in long-term outcomes.

    Recruiting at 2 sites De Viersprong · Amsterdam and 1 other locations · NCT07509216

  • Leadership and organizational program to help nurses use research in everyday care

    This project will test whether the LOCI leadership and organizational program helps nurses and managers in hospitals and elder care in Southwest Finland use research-based practices in everyday patient care.

    Recruiting University of Turku · Turku · NCT07378696

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.